Anti-SARS-CoV-2, Nucleocapsid (N) (COV19-6429)

Concentration: >=1.0 mg/mL; Formulation:Formulated in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.